Ayala Pharmaceuticals Shares Slide to New Lows on Advaxis Tie-Up >AYLA
marketwatch.com
news
2022-10-19 15:44:00

By Colin Kellaher Shares of Ayala Pharmaceuticals Inc. lost more than a quarter of their value and hit a new all-time low Wednesday after the clinical-stage oncology company said it would combine with biotechnology company Advaxis Inc. in a stock swap. Under the agreement, holders of Ayala's Nasdaq-listed shares would receive Advaxis shares equal to about 62.5% ownership in the combined company, Ayala and Advaxis said. Advaxis shares are currently traded in the over-the-counter markets, but the Monmouth Junction, N.
